Markt oder Branche auswählen:
Chart-Typ:
Zeitraum:
| XFRA DIVIDEND/INTEREST INFORMATION - 25.03.2020 - 1 | FOLGENDE WERTPAPIERE WERDEN AM 24.03.2020 CUM DIVIDENDE/ZINSEN UND AM 25.03.2020 EX DIVIDENDE/ZINSEN GEHANDELT. THE PRE-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL BE 24.03.2020. THE EX-DIVIDEND/INTEREST... ► Artikel lesen |
| XFRA WBJ: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL WEBJET LTD WBJ... ► Artikel lesen |
| Mesoblast - An important next several months | It is going to be a busy next several months for Mesoblast. The company recently completed filing the biologics license application (BLA) for Ryoncil (remestemcel-L) with the FDA for approval for the... ► Artikel lesen |
| Mesoblast - Moving closer to key catalysts | Mesoblast is approaching some very key catalysts. The company expects to complete its filing of Remestemcel-L in pediatric acute graft versus host disease (aGvHD) in January, which if approved, will... ► Artikel lesen |
| Mesoblast - Increasingly positive on aGvHD | With a positive primary endpoint plus 180-day data in acute graft versus host disease (aGvHD), Mesoblast is on track for its first US approval. Mesoblast is targeting US approval in H120 for GvHD and... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
